AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2024
Mar 8, 2024
31676_dirs_2024-03-07_4d91be3d-4d7f-4c20-bb8d-9766a51520a6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2024-03-07
Reporting Person: Mutz Christopher (HEAD OF RARE DISEASE)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-07 | Common Stock | F | 2110 | $66.71 | Disposed | 85277 | Direct |
Footnotes
F1: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported.
More from ANI PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3